Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.250 $0.685 Friday, 10th May 2024 ADXS stock ended at $0.437. This is 21.96% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 108.00% from a day low at $0.250 to a day high of $0.520.
90 days $0.250 $1.05
52 weeks $0.250 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Sep 16, 2016 $159.30 $159.30 $159.30 $159.30 49 653
Sep 15, 2016 $165.75 $165.75 $165.75 $165.75 63 973
Sep 14, 2016 $161.40 $161.40 $161.40 $161.40 41 707
Sep 13, 2016 $156.00 $156.00 $156.00 $156.00 61 307
Sep 12, 2016 $165.15 $165.15 $165.15 $165.15 80 947
Sep 09, 2016 $154.05 $154.05 $154.05 $154.05 73 467
Sep 08, 2016 $168.60 $168.60 $168.60 $168.60 39 300
Sep 07, 2016 $171.45 $171.45 $171.45 $171.45 71 507
Sep 06, 2016 $171.30 $171.30 $171.30 $171.30 48 680
Sep 02, 2016 $172.80 $172.80 $172.80 $172.80 57 147
Sep 01, 2016 $176.70 $176.70 $176.70 $176.70 35 720
Aug 31, 2016 $172.95 $172.95 $172.95 $172.95 72 340
Aug 30, 2016 $176.85 $176.85 $176.85 $176.85 41 113
Aug 29, 2016 $177.15 $177.15 $177.15 $177.15 46 553
Aug 26, 2016 $177.45 $177.45 $177.45 $177.45 54 880
Aug 25, 2016 $177.30 $177.30 $177.30 $177.30 87 440
Aug 24, 2016 $182.10 $182.10 $182.10 $182.10 94 460
Aug 23, 2016 $200.25 $200.25 $200.25 $200.25 92 947
Aug 22, 2016 $212.85 $212.85 $212.85 $212.85 82 680
Aug 19, 2016 $205.50 $205.50 $205.50 $205.50 55 960
Aug 18, 2016 $203.10 $203.10 $203.10 $203.10 38 447
Aug 17, 2016 $204.00 $204.00 $204.00 $204.00 51 667
Aug 16, 2016 $210.90 $210.90 $210.90 $210.90 111 500
Aug 15, 2016 $222.15 $222.15 $222.15 $222.15 57 807
Aug 12, 2016 $212.70 $212.70 $212.70 $212.70 68 400
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT